Re: A Special Meeting of Shareholders?
in response to
by
posted on
May 28, 2024 11:33PM
"isn't there several zenith trials that wrap up end of q2/June?"
the estimated trial result dates have been pushed back - following are trials ending in currently projected to end in 2024 or 2025
there is a phase 2b prostate cancer trial ending 12/24, a phase 2 advanced solid tumors ending 8/25, a phase I/II advanced solid tumors and lymphomas ending 7/25, a phase I NUT carcinoma and solid tumors ending 6/25, a phase Ib advanced triple negative breast cancer ending 12/25, a phase I colorectal cancer ending 6/25, a phase I/II NUT Carcinoma ending 12/24, a phase 2 squamous cell lung cancer ending 11/25, a continuation protocol for those experiencing benefit while treated with zen-3694 ending 12/24